Pharma and biotech executives and professionals, service providers and allied agencies are invited to attend the BioPharma Formulation & Delivery Nexus on November 14-25, 2024, in London, UK. Scientists, C-level executives, directors, and vice presidents from prestigious organizations in Europe and North America will attend the event. Industry leaders can harness the reach of the event platform to educate, learn and interact with an engaging audience from the BioPharma spectrum.
BioPharma Nexus is focused on creating a union among leading pharmaceutical and biotechnology entities, along with service providers. Their objective is to provide high-quality healthcare to patients all over the globe. At the BioPharma Nexus conferences, players can explore, discover and generate partnerships for scientific and healthcare collaborations.
London is the Mecca for global research, innovations and discoveries in the biotech arena. Leaders of the biotech & pharma sectors will attend the event to discuss useful insights on drug formulations and new approaches in delivery. They will share strategies to overcome challenges, emerging trends technologies, and advancements. The Biopharma Nexus is a viable platform for researchers, innovators, professionals, and service providers to engage in business deals and collaborations.
The event agenda is as:
- Discussion on the new modalities in drug development and formulations
- Innovative approach to drug delivery
- New developments in dosage forms
- Novel products, therapies, trends and technologies in drug formulation and delivery
The conference agenda includes discussion panels and keynote speaker sessions from industry experts, as well as presentations from new and established entities. During the networking breaks for drinks, food and entertainment, the attendees can mingle and interact for a better understanding of each other’s vision and working operations. The audience can meet the industry leaders, get their queries solved, and learn the latest trends in the drug formulation and discovery business.
To learn more, please visit https://ibn.fm/BUldQ.
About QualityStocks
QualityStocks (“QS”) is a specialized communications platform with a focus on private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, QS is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, QS brings its clients unparalleled recognition and brand awareness. QS is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-published: https://www.QualityStocks.com/Disclaimer
QualityStocks
Scottsdale, AZ
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
QualityStocks is powered by IBN
